Insider Trading & Ownership of Versant Venture Capital VI, L.P.
-
Location
-
San Francisco, CA
-
Summary
-
The estimated value of insider holdings of Versant Venture Capital VI, L.P. is at least $196,878,133 dollars as of 02 Oct 2025. Versant Venture Capital VI, L.P. is the 10%+ Owner of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $85.32M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $53.19M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $28.75M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Century Therapeutics, Inc. and owns shares of Century Therapeutics, Inc. (IPSC) stock worth about $18.13M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Contineum Therapeutics, Inc. and owns shares of Contineum Therapeutics, Inc. (CTNM) stock worth about $8.93M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $2.56M.
-
Signature
-
Versant Vantage II, LP By: Versant Vantage II GP, L.P. Its: General Partner By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Notify me when Versant Venture Capital VI, L.P. files a new Insider Trading report.
⭐ Subscribe ⭐